Published: 31 Mar 2022 | Report Code: 10248442 | Pages: 109
Europe DNA sequencing market was valued at $ 3,287.4 million in 2021 and will grow by 15.2% annually over 2021-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction. Highlighted with 32 tables and 57 figures, this 109-page report “Europe DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe DNA sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe DNA sequencing market in every aspect of the classification from perspectives of Offering, Sequencing Type, Technology, Application, End User, and Country. Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Consumables • Sequencing Services Based on Sequencing Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Sanger Sequencing • Next Generation Sequencing • Other Sequencing Types By Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Sequencing by Synthesis • Ion Semiconductor Sequencing • Chain Termination Sequencing • Pyrosequencing • Sequencing by Ligation (SBL) • Single-Molecule Real-Time Sequencing (SMRT) • Nanopore Sequencing • Other Technologies By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Biomarker Discovery • Diagnostics • Personalized Medicine • Reproductive Health • Forensics • Other Applications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Academics and Research Organizations • Pharmaceutical and Biotechnology Companies • Hospitals & Clinics • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Sequencing Type and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Agilent Technologies Inc. BGI Genomics Co., Ltd. Bio-Rad Laboratories Inc. Danaher Corporation (Integrated DNA Technologies Inc.) Eurofins Scientific SE F. Hoffmann-La Roche Ltd. Illumina Inc. Merck KGaA Pacific Biosciences of California Inc. PerkinElmer Inc. Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table Of Contents:
7 1.1 Industry Definition and Research Scope 7 1.1.1 Industry Definition 7 1.1.2 Research Scope 8 1.2 Research Methodology 11 1.2.1 Overview of Market Research Methodology 11 1.2.2 Market Assumption 12 1.2.3 Secondary Data 12 1.2.4 Primary Data 12 1.2.5 Data Filtration and Model Design 13 1.2.6 Market Size/Share Estimation 14 1.2.7 Research Limitations 15 1.3 Executive Summary 16 2 Market Overview and Dynamics 19 2.1 Market Size and Forecast 19 2.1.1 Impact of COVID-19 on World Economy 20 2.1.2 Impact of COVID-19 on the Market 22 2.2 Major Growth Drivers 24 2.3 Market Restraints and Challenges 31 2.4 Emerging Opportunities and Market Trends 34 2.5 Porter’s Fiver Forces Analysis 38 3 Segmentation of Europe Market by Offering 42 3.1 Market Overview by Offering 42 3.2 Instruments 44 3.3 Consumables 45 3.4 Sequencing Services 46 4 Segmentation of Europe Market by Sequencing Type 47 4.1 Market Overview by Sequencing Type 47 4.2 Sanger Sequencing 49 4.3 Next Generation Sequencing 50 4.4 Other Sequencing Types 51 5 Segmentation of Europe Market by Technology 52 5.1 Market Overview by Technology 52 5.2 Sequencing by Synthesis 54 5.3 Ion Semiconductor Sequencing 55 5.4 Chain Termination Sequencing 56 5.5 Pyrosequencing 57 5.6 Sequencing by Ligation (SBL) 58 5.7 Single-Molecule Real-Time Sequencing (SMRT) 59 5.8 Nanopore Sequencing 60 5.9 Other Technologies 61 6 Segmentation of Europe Market by Application 62 6.1 Market Overview by Application 62 6.2 Biomarker Discovery 64 6.3 Diagnostics 65 6.4 Personalized Medicine 66 6.5 Reproductive Health 67 6.6 Forensics 68 6.7 Other Applications 69 7 Segmentation of Europe Market by End User 70 7.1 Market Overview by End User 70 7.2 Academics and Research Organizations 72 7.3 Pharmaceutical and Biotechnology Companies 73 7.4 Hospitals & Clinics 74 7.5 Other End Users 75 8 European Market 2021-2031 by Country 76 8.1 Overview of European Market 76 8.2 Germany 79 8.3 U.K. 81 8.4 France 83 8.5 Spain 85 8.6 Italy 87 8.7 Russia 89 8.8 Rest of European Market 91 9 Competitive Landscape 93 9.1 Overview of Key Vendors 93 9.2 New Product Launch, Partnership, Investment, and M&A 96 9.3 Company Profiles 97 Agilent Technologies Inc. 97 BGI Genomics Co., Ltd. 99 Bio-Rad Laboratories Inc. 100 Danaher Corporation (Integrated DNA Technologies Inc.) 101 Eurofins Scientific SE 102 F. Hoffmann-La Roche Ltd. 103 Illumina Inc. 104 Merck KGaA 105 Pacific Biosciences of California Inc. 106 PerkinElmer Inc. 107 Thermo Fisher Scientific Inc. 108 RELATED REPORTS 109
List Of Tables:
Table 1. Snapshot of Europe DNA Sequencing Market in Balanced Perspective, 2021-2031 17 Table 2. World Economic Outlook, 2021-2031 21 Table 3. World Health Spending by Region, $ bn, 2013-2020 30 Table 4. Main Product Trends and Market Opportunities in Europe DNA Sequencing Market 34 Table 5. Europe DNA Sequencing Market by Offering, 2021-2031, $ mn 42 Table 6. Europe DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 47 Table 7. Europe DNA Sequencing Market by Technology, 2021-2031, $ mn 52 Table 8. Europe DNA Sequencing Market by Application, 2021-2031, $ mn 62 Table 9. Europe DNA Sequencing Market by End User, 2021-2031, $ mn 70 Table 10. Europe DNA Sequencing Market by Country, 2021-2031, $ mn 78 Table 11. Germany DNA Sequencing Market by Offering, 2021-2031, $ mn 80 Table 12. Germany DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 80 Table 13. Germany DNA Sequencing Market by End User, 2021-2031, $ mn 80 Table 14. U.K. DNA Sequencing Market by Offering, 2021-2031, $ mn 82 Table 15. U.K. DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 82 Table 16. U.K. DNA Sequencing Market by End User, 2021-2031, $ mn 82 Table 17. France DNA Sequencing Market by Offering, 2021-2031, $ mn 84 Table 18. France DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 84 Table 19. France DNA Sequencing Market by End User, 2021-2031, $ mn 84 Table 20. Spain DNA Sequencing Market by Offering, 2021-2031, $ mn 86 Table 21. Spain DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 86 Table 22. Spain DNA Sequencing Market by End User, 2021-2031, $ mn 86 Table 23. Italy DNA Sequencing Market by Offering, 2021-2031, $ mn 88 Table 24. Italy DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 88 Table 25. Italy DNA Sequencing Market by End User, 2021-2031, $ mn 88 Table 26. Russia DNA Sequencing Market by Offering, 2021-2031, $ mn 90 Table 27. Russia DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn 90 Table 28. Russia DNA Sequencing Market by End User, 2021-2031, $ mn 90 Table 29. DNA Sequencing Market in Rest of Europe by Country, 2021-2031, $ mn 92 Table 30. Agilent Technologies Inc.: Company Snapshot 97 Table 31. Agilent Technologies Inc.: Business Segmentation 98 Table 32. Agilent Technologies Inc.: Product Portfolio 98
List Of Figures:
Figure 1. Research Method Flow Chart 11 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14 Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16 Figure 4. Europe DNA Sequencing Market, 2021-2031, $ mn 19 Figure 5. Impact of COVID-19 on Business 22 Figure 6. Primary Drivers and Impact Factors of Europe DNA Sequencing Market 24 Figure 7. World Number of Deaths by Cause in 2017 27 Figure 8. World Number of Deaths from Cancers in 2017 28 Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 29 Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 29 Figure 11. Primary Restraints and Impact Factors of Europe DNA Sequencing Market 31 Figure 12. Investment Opportunity Analysis 35 Figure 13. Porter’s Fiver Forces Analysis of Europe DNA Sequencing Market 38 Figure 14. Breakdown of Europe DNA Sequencing Market by Offering, 2021-2031, % of Revenue 43 Figure 15. Europe Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 43 Figure 16. Europe DNA Sequencing Market by Offering: Instruments, 2021-2031, $ mn 44 Figure 17. Europe DNA Sequencing Market by Offering: Consumables, 2021-2031, $ mn 45 Figure 18. Europe DNA Sequencing Market by Offering: Sequencing Services, 2021-2031, $ mn 46 Figure 19. Breakdown of Europe DNA Sequencing Market by Sequencing Type, 2021-2031, % of Sales Revenue 48 Figure 20. Europe Addressable Market Cap in 2022-2031 by Sequencing Type, Value ($ mn) and Share (%) 48 Figure 21. Europe DNA Sequencing Market by Sequencing Type: Sanger Sequencing, 2021-2031, $ mn 49 Figure 22. Europe DNA Sequencing Market by Sequencing Type: Next Generation Sequencing, 2021-2031, $ mn 50 Figure 23. Europe DNA Sequencing Market by Sequencing Type: Other Sequencing Types, 2021-2031, $ mn 51 Figure 24. Breakdown of Europe DNA Sequencing Market by Technology, 2021-2031, % of Sales Revenue 53 Figure 25. Europe Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 53 Figure 26. Europe DNA Sequencing Market by Technology: Sequencing by Synthesis, 2021-2031, $ mn 54 Figure 27. Europe DNA Sequencing Market by Technology: Ion Semiconductor Sequencing, 2021-2031, $ mn 55 Figure 28. Europe DNA Sequencing Market by Technology: Chain Termination Sequencing, 2021-2031, $ mn 56 Figure 29. Europe DNA Sequencing Market by Technology: Pyrosequencing, 2021-2031, $ mn 57 Figure 30. Europe DNA Sequencing Market by Technology: Sequencing by Ligation (SBL), 2021-2031, $ mn 58 Figure 31. Europe DNA Sequencing Market by Technology: Single-Molecule Real-Time Sequencing (SMRT), 2021-2031, $ mn 59 Figure 32. Europe DNA Sequencing Market by Technology: Nanopore Sequencing, 2021-2031, $ mn 60 Figure 33. Europe DNA Sequencing Market by Technology: Other Technologies, 2021-2031, $ mn 61 Figure 34. Breakdown of Europe DNA Sequencing Market by Application, 2021-2031, % of Revenue 63 Figure 35. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 63 Figure 36. Europe DNA Sequencing Market by Application: Biomarker Discovery, 2021-2031, $ mn 64 Figure 37. Europe DNA Sequencing Market by Application: Diagnostics, 2021-2031, $ mn 65 Figure 38. Europe DNA Sequencing Market by Application: Personalized Medicine, 2021-2031, $ mn 66 Figure 39. Europe DNA Sequencing Market by Application: Reproductive Health, 2021-2031, $ mn 67 Figure 40. Europe DNA Sequencing Market by Application: Forensics, 2021-2031, $ mn 68 Figure 41. Europe DNA Sequencing Market by Application: Other Applications, 2021-2031, $ mn 69 Figure 42. Breakdown of Europe DNA Sequencing Market by End User, 2021-2031, % of Revenue 71 Figure 43. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 71 Figure 44. Europe DNA Sequencing Market by End User: Academics and Research Organizations, 2021-2031, $ mn 72 Figure 45. Europe DNA Sequencing Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn 73 Figure 46. Europe DNA Sequencing Market by End User: Hospitals & Clinics, 2021-2031, $ mn 74 Figure 47. Europe DNA Sequencing Market by End User: Other End Users, 2021-2031, $ mn 75 Figure 48. Breakdown of European DNA Sequencing Market by Country, 2021 and 2031, % of Revenue 77 Figure 49. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 78 Figure 50. DNA Sequencing Market in Germany, 2021-2031, $ mn 79 Figure 51. DNA Sequencing Market in U.K., 2021-2031, $ mn 81 Figure 52. DNA Sequencing Market in France, 2021-2031, $ mn 83 Figure 53. DNA Sequencing Market in Spain, 2021-2031, $ mn 85 Figure 54. DNA Sequencing Market in Italy, 2021-2031, $ mn 87 Figure 55. DNA Sequencing Market in Russia, 2021-2031, $ mn 89 Figure 56. DNA Sequencing Market in Rest of Europe, 2021-2031, $ mn 91 Figure 57. Growth Stage of Europe DNA Sequencing Industry over the Forecast Period 93
Selected Key Players: Agilent Technologies Inc. BGI Genomics Co., Ltd. Bio-Rad Laboratories Inc. Danaher Corporation (Integrated DNA Technologies Inc.) Eurofins Scientific SE F. Hoffmann-La Roche Ltd. Illumina Inc. Merck KGaA Pacific Biosciences of California Inc. PerkinElmer Inc. Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)